Kristina Kirschner
krikirschner.bsky.social
Kristina Kirschner
@krikirschner.bsky.social
Professor interested in how aging drives hematopoietic stem cell dynamics at Mayo Clinic, MN https://www.mayo.edu/research/labs/stem-cell-aging-cancer/overview
Our framework enables more accurate prediction of CH's clinical impact, moving us closer to personalized risk assessment and potential intervention strategies.
March 7, 2025 at 1:10 PM
MACS120 outperformed traditional measurements (like variant allele frequency) in predicting mortality risk and showed increased correlations with the speed of change in blood markers like lymphocyte and albumin levels.
March 7, 2025 at 1:10 PM
Considering these factors, we developed MACS120 - a novel metric that combines mutation fitness and acquisition timing to predict maximum clone size a mutation will reach over a lifetime.
March 7, 2025 at 1:10 PM
Third, we discovered a strong correlation between mutation timing, or age at time of mutation acquisition (ATMA), and fitness. Higher fitness mutations tend to appear later in life - possibly due to declining quality control mechanisms with age.
March 7, 2025 at 1:10 PM
Similarly, mutations can have different fitness effects depending on what other mutations are present in the same clone. For example, ASXL1 mutations have higher fitness when co-occurring with SRSF2 than with TET2.
March 7, 2025 at 1:10 PM
Second, we found that clonal coexistence matters! Mutations don't grow in isolation - when multiple clones are present in the same person, they alter each other's overall contribution to the production of blood cells.
March 7, 2025 at 1:10 PM
First, we confirmed gene-specific fitness differences: RNA splicing mutations (like U2AF1, U2AF2) show higher fitness than epigenetic regulator mutations (like DNMT3A, TET2).
March 7, 2025 at 1:10 PM
Our key insight: Three factors, mutation fitness (growth advantage), mutation timing, and clonal structure (which mutations occur together) are needed to understand the progression and clinical impact of CH.
March 7, 2025 at 1:10 PM
We integrated data from 713 individuals across 3 longitudinal aging cohorts (2,341 observations total) and developed models to understand the dynamics of CH mutations over time. #CancerResearch #ClonalHematopoiesis
March 7, 2025 at 1:10 PM
Clonal hematopoiesis (CH) is common in aging populations and associated with increased risk of blood cancers and other diseases. But what determines which CH mutations will progress to disease?
March 7, 2025 at 1:10 PM
Excited to be part of this amazing workshop. Thanks for organising @megvoda.bsky.social
December 6, 2024 at 2:16 AM
Pleasure to host you as always!
December 5, 2024 at 2:29 PM
Congratulations on this nice piece of work!
November 29, 2024 at 5:55 PM